Tandem Diabetes Care Inc [TNDM] stock prices are up 10.92% to $22.44 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TNDM shares have gain 8.77% over the last week, with a monthly amount drifted -2.35%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tandem Diabetes Care Inc [NASDAQ: TNDM] stock has seen the most recent analyst activity on April 10, 2025, when Mizuho initiated its Neutral rating and assigned the stock a price target of $20. Previously, Morgan Stanley downgraded its rating to Equal-Weight on March 05, 2025, and dropped its price target to $22. On March 04, 2025, downgrade downgraded it’s rating to Neutral and revised its price target to $24 on the stock. Wells Fargo downgraded its rating to a Equal Weight and decreased its price target to $22 on March 03, 2025. Bernstein downgraded its rating to a Mkt Perform and reduced its price target to $25 on February 28, 2025. Morgan Stanley upgraded its rating to Overweight for this stock on December 02, 2024, but kept the price target unchanged to $45. In a note dated November 06, 2024, Bernstein initiated an Outperform rating and provided a target price of $42 on this stock.
The stock price of Tandem Diabetes Care Inc [TNDM] has been fluctuating between $15.75 and $49.71 over the past year. Currently, Wall Street analysts expect the stock to reach $33.33 within the next 12 months. Tandem Diabetes Care Inc [NASDAQ: TNDM] shares were valued at $22.44 at the most recent close of the market. An investor can expect a potential return of 48.53% based on the average TNDM price forecast.
Analyzing the TNDM fundamentals
The Tandem Diabetes Care Inc [NASDAQ:TNDM] reported sales of 982.95M for trailing twelve months, representing a surge of 22.30%. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -0.16%, Pretax Profit Margin comes in at -0.16%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.83 and Total Capital is -0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Tandem Diabetes Care Inc [NASDAQ:TNDM]’s Current Ratio is 2.30. In addition, the Quick Ratio stands at 1.81 and the Cash Ratio stands at 0.19. Considering the valuation of this stock, the price to sales ratio is 1.52, the price to book ratio is 9.62.
Transactions by insiders
Recent insider trading involved Kyrillos Jean-Claude, EVP & Chief Operating Officer, that happened on Mar 07 ’25 when 10538.0 shares were purchased. Director, BLICKENSTAFF KIM D completed a deal on Nov 21 ’24 to sell 30000.0 shares. Meanwhile, Director BLICKENSTAFF KIM D sold 10000.0 shares on Nov 20 ’24.
